Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alyssa K. Chapman
Observed names:
Alyssa Chapman,
Chapman Alyssa
Institutions:
Frederick National Laboratory for Cancer Research,
Leidos Biomedical Research Inc. (United States)
Observed institutions:
Frederick National Laboratory for Cancer Research,
Leidos Biomedical Research Inc. (United States)
ORCID:
0009-0003-8213-3754
Observed ORCID:
0009-0003-8213-3754
OpenAlex ID:
A5072749934
Analysis of 20 Independently Performed Assays to Measure Homologous Recombination Deficiency (HRD) in Ovarian Cancer: Findings From the Friends' HRD Harmonization Project
2024
·
Hillary S. Andrews
, Lisa M. McShane
, et al.
·
JCO oncology advances.
·
17
Abstract A017: An analysis of 13 independently performed assays to measure homologous recombination deficiency using 90 freshly extracted high grade serous ovarian tumors: findings from the friends of cancer research hrd harmonization project
2024
·
Hillary Stires
, Lisa M. McShane
, et al.
·
Cancer Research
·
1
Abstract 3916: Patient-derived organoid and cell culture models from the NCI Patient-Derived Models Repository (NCI PDMR) preserve genomic stability and heterogeneity of patient tumor specimens
2020
·
Biswajit Das
, Yvonne A. Evrard
, et al.
·
Cancer Research
·
1
Abstract A005: MGMT as a pan-cancer biomarker in temozolomide preclinical studies using models from the NCI PDMR
2025
·
Li Chen
, Shahanawaz Jiwani
, et al.
·
Molecular Cancer Therapeutics
Abstract 5078: Single-cell characterization of a carcinosarcoma patient-derived xenograft model
2025
·
Alida Palmisano
, Yuri Kotliarov
, et al.
·
Cancer Research
Abstract 489: Unveiling markers of response to ATR inhibitor and TMZ combinations in rare tumor PDXs
2025
·
Yingdong Zhao
, Mariam M. Konate
, et al.
·
Cancer Research
Abstract 6914: Genomic landscape and stability of preclinical models in NCI's patient-derived models repository
2024
·
Ting-Chia Chang
, Biswajit Das
, et al.
·
Cancer Research
Abstract 6072: Chromosomal aneuploidy, whole-genome doubling and mutational signatures in NCI PDMR models
2023
·
Li Chen
, Biswajit Das
, et al.
·
Cancer Research
Abstract 2050: Molecular subclassification of NCI PDMR breast cancer models using PAM50 gene expression signature
2023
·
Peter I. Wu
, Lindsay Dutko
, et al.
·
Cancer Research
Abstract 80: Genomic characterization of PDX models from rare cancer patients in the NCI Patient-Derived Models Repository
2022
·
Li Chen
, Rini Pauly
, et al.
·
Cancer Research
Abstract 1913: Quality control workflows developed for the NCI Patient-Derived Models Repository using low pass whole genome sequencing and whole exome sequencing
2022
·
Ting-Chia Chang
, Li Chen
, et al.
·
Cancer Research
Abstract 973: Comparative single cell transcriptome profiling of primary tumors, CTCs and metastatic sites from a bladder cancer PDX model
2022
·
Tomas Vilimas
, Brandie Fullmer
, et al.
·
Cancer Research
Abstract P097: Comparative single cell transcriptome profiling of primary tumors, CTCs and metastatic sites from a bladder cancer PDX model
2021
·
Tomas Vilimas
, Brandie Fullmer
, et al.
·
Molecular Cancer Therapeutics
Abstract 3139: Study of tumor heterogeneity and subclonality in primary pancreatic and metastatic sites from rapid autopsy patients in PDMR
2021
·
Li Chen
, Biswajit Das
, et al.
·
Cancer Research
Abstract 3554: Genomic landscape of acquired uniparental disomy in NCI PDMR patient derived xenograft models
2020
·
Rajesh Patidar
, Li Chen
, et al.
·
Cancer Research
Show more works
View as search
Works count:
15
Citation count:
19
H-index:
1
I10-index:
1
Year
Topic
Type